Notice of Meeting, 44537 [2020-15932]
Download as PDF
Federal Register / Vol. 85, No. 142 / Thursday, July 23, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
Agency for Healthcare Research and
Quality
[FR Doc. 2020–15933 Filed 7–22–20; 8:45 am]
BILLING CODE 4160–90–P
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
ACTION:
Notice.
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HSQR ZHS1 HSR X–
(02).’’ This SEP meeting will be closed
to the public.
SUMMARY:
DATES:
August 19, 2020.
Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ–HSQR ZHS1 HSR X–(02).’’ are
to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:10 Jul 22, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
44537
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Agency for Healthcare Research and
Quality
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
Notice of Meeting
[FR Doc. 2020–15932 Filed 7–22–20; 8:45 am]
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘AHRQ RFAHS20–
002 Supporting Primary Care to
Advance Cardiovascular Health in
States with High Prevalence of
Preventable CVD Events (U18).’’ This
SEP meeting will be closed to the
public.
SUMMARY:
August 25, 2020.
Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by AHRQ, and agree to
be available, to conduct on an as needed
basis, scientific reviews of applications
for AHRQ support. Individual members
of the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ RFAHS20–002 Supporting
Primary Care to Advance Cardiovascular
Health in States with High Prevalence of
Preventable CVD Events (U18).’’ are to
be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
DATES:
ADDRESSES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘AHRQ RFAHS20–
003 Novel, High-Impact Studies
Evaluating Health System and
Healthcare Professional Responsiveness
to COVID–19 (R01).’’ This SEP meeting
will be closed to the public.
DATES: August 27–28, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850. Telephone:
(301)427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
Agencies
[Federal Register Volume 85, Number 142 (Thursday, July 23, 2020)]
[Notices]
[Page 44537]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15932]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``AHRQ RFAHS20-002
Supporting Primary Care to Advance Cardiovascular Health in States with
High Prevalence of Preventable CVD Events (U18).'' This SEP meeting
will be closed to the public.
DATES: August 25, 2020.
ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20850.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland 20850, Telephone: (301) 427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly-scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. App. 2, section
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications
for the ``AHRQ RFAHS20-002 Supporting Primary Care to Advance
Cardiovascular Health in States with High Prevalence of Preventable CVD
Events (U18).'' are to be reviewed and discussed at this meeting. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-15932 Filed 7-22-20; 8:45 am]
BILLING CODE 4160-90-P